Product Images Dobutamine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Dobutamine NDC 51662-1337 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51662 1337 2 Pouch Labeling

51662 1337 2 Pouch Labeling

51662 1337 3 Case Labeling

51662 1337 3 Case Labeling

DOSAGE 1 - DOSAGE 1

DOSAGE 1 - DOSAGE 1

DOSAGE 2 - DOSAGE 2

DOSAGE 2 - DOSAGE 2

This is a table presenting the Dobutamine infusion rate (in mL per hour) at different drug delivery rates (in mcg/kg/min) and patient body weights (in kg) for three different concentrations of Dobutamine (500 mcg/mL, 1000 mcg/mL, and 2000 mcg/mL). The table allows for the calculation of the appropriate Dobutamine infusion rate given a specific drug delivery rate, patient body weight, and Dobutamine concentration.*

HOW SUPPLIED - HOW SUPPLIED

HOW SUPPLIED - HOW SUPPLIED

This is a medication description stating the unit of sale which is a carton containing one single-dose vial of 250mg/20mL (12.5mg/mL) concentration. The medication has an NDC code of 0409-2344-01. Additionally, the medication is also available in a tray containing ten vials with an NDC code of 0409-2344-02 as well as a 20mL single-dose vial with the NDC code of 0409-2344-62.*

LOGO - LOGO

LOGO - LOGO

SERIALIZED LABEL - SERIALIZED VIAL

SERIALIZED LABEL - SERIALIZED VIAL

STRUCTURE - STRUCTURE

STRUCTURE - STRUCTURE

VIAL LABEL - VIAL LABEL

VIAL LABEL - VIAL LABEL

This is a description of a medication called Dobutamine Injection, USP, which is only available with a prescription. It comes in a 250 mg/20mL dosage, with each mL containing 12.5 mg of dobutamine. The medication is designed for intravenous use only and requires dilution before use. It should be used within 24 hours of dilution. Specific instructions for dosage and administration are included in an insert. The medication is manufactured by Lonkusa RL-7042 Hospira and may contain sodium hydroxide or yarochioic acid_angjor, depending on pH adjustments.*

rfid

rfid

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.